Growth Metrics

Conmed (CNMD) Short-Term Debt repayments (2016 - 2025)

Conmed (CNMD) has disclosed Short-Term Debt repayments for 10 consecutive years, with $187.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Short-Term Debt repayments rose 0.54% year-over-year to $187.0 million, compared with a TTM value of $695.4 million through Dec 2025, down 7.65%, and an annual FY2025 reading of $695.4 million, down 7.65% over the prior year.
  • Short-Term Debt repayments was $187.0 million for Q4 2025 at Conmed, up from $171.0 million in the prior quarter.
  • Across five years, Short-Term Debt repayments topped out at $230.0 million in Q2 2024 and bottomed at $72.0 million in Q1 2021.
  • Average Short-Term Debt repayments over 5 years is $156.6 million, with a median of $168.5 million recorded in 2024.
  • The sharpest move saw Short-Term Debt repayments skyrocketed 206.9% in 2021, then decreased 25.46% in 2025.
  • Year by year, Short-Term Debt repayments stood at $121.0 million in 2021, then increased by 4.13% to $126.0 million in 2022, then surged by 58.73% to $200.0 million in 2023, then fell by 7.0% to $186.0 million in 2024, then increased by 0.54% to $187.0 million in 2025.
  • Business Quant data shows Short-Term Debt repayments for CNMD at $187.0 million in Q4 2025, $171.0 million in Q3 2025, and $171.4 million in Q2 2025.